European Medicines Agency Human Scientific Committees' Working Parties with Patients' and Consumers' Organisations (PCWP) and Healthcare Professionals' Organisations (HCPWP) joint meeting
Date:
17/09/2015
Location:
European Medicines Agency, London, UK
This is a joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. Participants will discuss the PCWP/HCPWP work programmes for 2016. They will be updated on a number of initiatives and ongoing activities including the need for collaboration in pharmacovigilance to ensure effective health protection and promotion, the new pharmacovigilance systems and services. Participants will be presented with the results of the survey to National Competent Authorities and the results from VISUALIZE research study (PROTECT project). Other topics including the progress of the PCWP/HCPWP topic groups, feedback from the scientific committees, patients' and consumers' and healthcare professionals' organisations projects and initiatives will also be presented. Registration by invitation only.
-
List item
Agenda - European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting on 17 September 2015 (PDF/163.45 KB)
Adopted
First published: 04/08/2015
Last updated: 11/12/2015
EMA/347054/2015 -
List item
Minutes of the EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting (PDF/198.43 KB)
First published: 11/12/2015
Last updated: 11/12/2015
EMA/528328/2015 -
List item
newList of participants of the EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting (PDF/144.34 KB)
First published: 11/12/2015
Last updated: 11/12/2015
EMA/407107/2015 -
List item
Presentation - Visualizing uncertainty among laypersons and experts (Andrea Beyer) (PDF/854.6 KB)
First published: 11/12/2015
Last updated: 11/12/2015 -
List item
Presentation - Need for collaboration in pharmacovigilance to ensure effective health protection and promotion (Jacoline Bouvy) (PDF/272.94 KB)
First published: 11/12/2015
Last updated: 11/12/2015 -
List item
Presentation - New pharmacovigilance systems and services (Peter Arlett) (PDF/692.11 KB)
First published: 11/12/2015
Last updated: 11/12/2015 -
List item
Presentation - New pharmacovigilance systems and services (Helen Vella) (PDF/342.4 KB)
First published: 11/12/2015
Last updated: 11/12/2015 -
List item
Presentation - Herbal medicinal products – an area of patient involvement? (Steffen Bager) (PDF/1.07 MB)
First published: 11/12/2015
Last updated: 11/12/2015 -
List item
Presentation - Implementation of new eligibility requirements and working party mandates for 2016-2019 (Nathalie Bere and Ivana Silva) (PDF/170.29 KB)
First published: 11/12/2015
Last updated: 11/12/2015 -
List item
Presentation - Opportunities and challenges for the European Network of MS Registries in 2016 -2020 (PDF/905.62 KB)
First published: 11/12/2015
Last updated: 11/12/2015 -
List item
Presentation - European consortium study on the availability of anti-neoplastic medicines (Alexandru Eniu and Nathan I Cherny) (PDF/2.89 MB)
First published: 11/12/2015
Last updated: 11/12/2015